Cargando…
Mechanistic Insights and Potential Therapeutic Approaches in PolyQ Diseases via Autophagy
Polyglutamine diseases are a group of congenital neurodegenerative diseases categorized with genomic abnormalities in the expansion of CAG triplet repeats in coding regions of specific disease-related genes. Protein aggregates are the toxic hallmark for polyQ diseases and initiate neuronal death. Au...
Autores principales: | Jain, Mukul, Patil, Nil, Abdi, Gholamreza, Abbasi Tarighat, Maryam, Mohammed, Arifullah, Ahmad Mohd Zain, Muhammad Rajaei, Goh, Khang Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856063/ https://www.ncbi.nlm.nih.gov/pubmed/36672670 http://dx.doi.org/10.3390/biomedicines11010162 |
Ejemplares similares
-
Coaggregation of polyglutamine (polyQ) proteins is mediated by polyQ-tract interactions and impairs cellular proteostasis: Coaggregation of polyQ proteins
por: Hong, Jun-Ye, et al.
Publicado: (2023) -
PolyQ 2.0: an improved version of PolyQ, a database of human polyglutamine proteins
por: Li, Chen, et al.
Publicado: (2016) -
PolyQ 2.0: an improved version of PolyQ, a database of human polyglutamine proteins
por: Li, Chen, et al.
Publicado: (2016) -
Small-molecule modulators of TRMT2A decrease PolyQ aggregation and PolyQ-induced cell death
por: Margreiter, Michael A, et al.
Publicado: (2021) -
Undoing SUMO aids polyQ AR
por: Lieberman, Andrew P., et al.
Publicado: (2015)